Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bennouna

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
Oncology|November 29, 2002
A phase II study with 5-fluorouracil, folinic acid and oxaliplatin (FOLFOX-4 regimen) in patients with metastatic renal cell carcinomaJ Bennouna, R Delva, F Gomez, et al.
Journal of Cell Science|February 15, 2001
Protective role of Bcl2 in metabolic oxidative stress-induced cell deathY J Lee, J C Chen, A A Amoscato, et al.
Oncology|July 16, 2005
A phase II trial of raltitrexed (Tomudex) in advanced pancreatic and biliary carcinomaEric François, M Hebbar, J Bennouna, et al.
European Journal of Cancer (Oxford, England : 1990)|June 16, 2000
A phase II study of docetaxel and vinorelbine combination chemotherapy in patients with advanced non-small cell lung cancerJ Bennouna, A Monnier, A Rivière, et al.
British Journal of Cancer|May 5, 2001
Combined paclitaxel and gemcitabine as first-line treatment in metastatic non-small cell lung cancer: a multicentre phase II studyJ Y Douillard, D Lerouge, A Monnier, et al.
British Journal of Cancer|November 19, 2009
Quality-of-life findings from a randomised phase-III study of XELOX vs FOLFOX-6 in metastatic colorectal cancerT Conroy, M Hebbar, J Bennouna, et al.
Oncology|March 2, 2011
Cost-minimisation analysis in first-line treatment of metastatic colorectal cancer in France: XELOX versus FOLFOX-6G Perrocheau, J Bennouna, M Ducreux, et al.
European Journal of Cancer (Oxford, England : 1990)|February 14, 2004
Patient preference for either the EORTC QLQ-C30 or the FACIT Quality Of Life (QOL) measures: a study performed in patients suffering from carcinoma of an unknown primary site (CUP)C Rodary, V Pezet-Langevin, S Garcia-Acosta, et al.
Cancer Chemotherapy and Pharmacology|March 3, 2012
Phase I dose-escalation study of vinflunine hard capsules administered twice a day for 2 consecutive days every week in patients with advanced/metastatic solid tumorsE Calvo, J B Vermorken, S Hiret, et al.
British Journal of Cancer|April 28, 2006
Vinflunine -- an active chemotherapy for treatment of advanced non-small-cell lung cancer previously treated with a platinum-based regimen: results of a phase II studyJ Bennouna, J-L Breton, J-M Tourani, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
Oncology|November 29, 2002
A phase II study with 5-fluorouracil, folinic acid and oxaliplatin (FOLFOX-4 regimen) in patients with metastatic renal cell carcinomaJ Bennouna, R Delva, F Gomez, et al.
Journal of Cell Science|February 15, 2001
Protective role of Bcl2 in metabolic oxidative stress-induced cell deathY J Lee, J C Chen, A A Amoscato, et al.
Oncology|July 16, 2005
A phase II trial of raltitrexed (Tomudex) in advanced pancreatic and biliary carcinomaEric François, M Hebbar, J Bennouna, et al.
European Journal of Cancer (Oxford, England : 1990)|June 16, 2000
A phase II study of docetaxel and vinorelbine combination chemotherapy in patients with advanced non-small cell lung cancerJ Bennouna, A Monnier, A Rivière, et al.
British Journal of Cancer|May 5, 2001
Combined paclitaxel and gemcitabine as first-line treatment in metastatic non-small cell lung cancer: a multicentre phase II studyJ Y Douillard, D Lerouge, A Monnier, et al.
British Journal of Cancer|November 19, 2009
Quality-of-life findings from a randomised phase-III study of XELOX vs FOLFOX-6 in metastatic colorectal cancerT Conroy, M Hebbar, J Bennouna, et al.
Oncology|March 2, 2011
Cost-minimisation analysis in first-line treatment of metastatic colorectal cancer in France: XELOX versus FOLFOX-6G Perrocheau, J Bennouna, M Ducreux, et al.
European Journal of Cancer (Oxford, England : 1990)|February 14, 2004
Patient preference for either the EORTC QLQ-C30 or the FACIT Quality Of Life (QOL) measures: a study performed in patients suffering from carcinoma of an unknown primary site (CUP)C Rodary, V Pezet-Langevin, S Garcia-Acosta, et al.
Cancer Chemotherapy and Pharmacology|March 3, 2012
Phase I dose-escalation study of vinflunine hard capsules administered twice a day for 2 consecutive days every week in patients with advanced/metastatic solid tumorsE Calvo, J B Vermorken, S Hiret, et al.
British Journal of Cancer|April 28, 2006
Vinflunine -- an active chemotherapy for treatment of advanced non-small-cell lung cancer previously treated with a platinum-based regimen: results of a phase II studyJ Bennouna, J-L Breton, J-M Tourani, et al.
Pageof 6